Sofinnova Crossover I - 14 Feb 2025 SCHEDULE 13D/A Report for Abivax SA Ordinary Shares, par value EUR0.01 per share (ABVX)

Filing Manager
Sofinnova Crossover I
Reporting Manager
Sofinnova Crossover I SLP
Security
Abivax SA Ordinary Shares, par value EUR0.01 per share
Symbol
ABVX
Shares outstanding
70,858,891 shares
Disclosed Ownership
7,794,478 shares
Ownership
11%
Form type
SCHEDULE 13D/A
Filing time
14 Feb 2025, 16:19:20 UTC
Date of event
14 Feb 2025
Next filing
31 Jul 2025
SEC
View on sec.gov

Reporting Managers (7)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Sofinnova Crossover I SLP 11% 7,794,478 7,794,478 0 /s/ Antoine Papiernik Managing Partner 0001845105
Sofinnova Partners SAS 11% 7,794,478 7,794,478 0 /s/ Antoine Papiernik Managing Partner 0001574139
Antoine Papiernik 11% 7,794,478 7,794,478 0 /s/ Antoine Papiernik Antoine Papiernik 0001768408
Cedric Moreau 11% 7,794,478 7,794,478 0 /s/ Cedric Moreau Cedric Moreau
Kinam Hong 11% 7,794,478 7,794,478 0 /s/ Kinam Hong Kinam Hong
Joseph Anderson 11% 7,794,478 7,794,478 0 /s/ Joseph Anderson Joseph Anderson
Jacques Theurillat 11% 7,794,478 7,794,478 0 /s/ Jacques Theurillat Jacques Theurillat